Drug Trial Radar · NCT00408200
A Study of the Effectiveness of Anti-Arrhythmic Medications After Atrial Fibrillation Ablation
Last checked: Nov 20, 2026Latest source record: Mar 7, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
110
Actual
Start
Nov 2006
Primary completion
Apr 2008
Study completion Jun 2008
Sponsor
- Lead sponsor
- University of PennsylvaniaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 6, 2006
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to examine the overall effectiveness of anti-arrhythmic medicines (to control heart rhythm) prescribed after an ablation procedure for atrial fibrillation.
Conditions
- Atrial Fibrillation
Interventions
propafenone; flecainide; sotalol; dofetilideDrug
Above drugs prescribed per established guidelines for treatment of AF
Radiofrequency catheter ablationDevice
A special catheter that delivers radiofrequency (heat) energy is advanced into the heart and used to destroy small areas of heart tissue responsible for causing atrial fibrillation. All catheters / devices used in the study are FDA approved for human use and currently being used to perform the AF ablation procedure in the United Sates.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite Endpoint: Atrial Arrhythmias Lasting >24 Hrs or Requiring Antiarrhythmic Drug Therapy; Need for Cardioversion/Repeat Ablation During the Study Period; Adverse Outcome/Intolerance of Antiarrhythmic Agent Requiring Cessation or Change of DrugTime frame: 6 weeks
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
Presbyterian Medical Center
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.